<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: PR Newswire: Personnel Announcements</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: PR Newswire: Personnel Announcements</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
									<item>
				<title>Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor</title>
				<description>INDIANAPOLIS, November 13 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Steven M. Paul,
M.D., executive vice president, science and technology, and president, Lilly
Research...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3982</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3982</guid>
				<pubDate>Fri, 13 Nov 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>William Cork Joins Fenwal as Chief Technology Officer</title>
				<description>LAKE ZURICH, Illinois, November 10 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving
blood collection, separation, safety and availability, announced today
William...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3958</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3958</guid>
				<pubDate>Tue, 10 Nov 2009 16:53:00 +0000</pubDate>
			</item>
					<item>
				<title>Allied World&#039;s Eugene Raitt Elected 2010 Chairman of the Board for the Direct Marketing Association</title>
				<description>PEMBROKE, Bermuda, November 4 /PRNewswire/ -- Allied World Assurance Company, Ltd, a member company of Allied World
Assurance Company Holdings, Ltd (NYSE: AWH) today announced that Eugene
Raitt,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3924</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3924</guid>
				<pubDate>Wed, 04 Nov 2009 03:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New Shire Board Member</title>
				<description>DUBLIN, Ireland, November 2 /PRNewswire/ -- The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY) announces
that Mr David Stout joined the Board as a Non Executive Director with effect
from...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3912</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3912</guid>
				<pubDate>Mon, 02 Nov 2009 10:23:00 +0000</pubDate>
			</item>
					<item>
				<title>Raptor Pharmaceutical Expands Board of Directors</title>
				<description>NOVATO, California, October 1 /PRNewswire/ -- Raptor Pharmaceutical Corp. (&quot;Raptor&quot; or the &quot;Company&quot;) (Nasdaq: RPTPD),
today announced the appointment of Llew Keltner, M.D., Ph.D., to the
Company&#039;s...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3744</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3744</guid>
				<pubDate>Thu, 01 Oct 2009 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Stephen W. Borron, M.D., Named Medical Editor-In-Chief of ToxED</title>
				<description>PHILADELPHIA, September 28 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and
medical information announced today that, the Stephen W. Borron, M.D., has
been named Medical...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3726</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3726</guid>
				<pubDate>Mon, 28 Sep 2009 10:22:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT Appoints New Chief Executive Officer</title>
				<description>AMSTERDAM, September 24 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
human gene therapy, announced today the appointment of Jorn Aldag as its new
Chief Executive...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3707</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3707</guid>
				<pubDate>Thu, 24 Sep 2009 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New Appointments at London Genetics to Drive Strategy Forward</title>
				<description>LONDON, September 18 /PRNewswire/ -- London Genetics Limited, which expedites pharmacogenetic
partnerships between the biopharmaceutical industry and London-based centres
of excellence in genetics...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3671</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3671</guid>
				<pubDate>Fri, 18 Sep 2009 16:04:00 +0000</pubDate>
			</item>
					<item>
				<title>NeuroFocus Names Dr. Steven Miller to Head Global Neurological Laboratory Operations</title>
				<description>BERKELEY, California, September 18 /PRNewswire/ -- NeuroFocus, the world&#039;s leading neuromarketing company, announced that it
has named Dr. Steven L. Miller to lead its neurological testing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3669</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3669</guid>
				<pubDate>Fri, 18 Sep 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New Nominee for WHO Regional Director for Europe</title>
				<description>COPENHAGEN, September 16 /PRNewswire/ -- Zsuzsanna Jakab has been nominated as the new WHO Regional Director for
Europe by the WHO European Region&#039;s governing body in Copenhagen. Mrs Jakab,
the first...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3655</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3655</guid>
				<pubDate>Wed, 16 Sep 2009 13:19:00 +0000</pubDate>
			</item>
					<item>
				<title>New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations</title>
				<description>HOERSHOLM, Denmark and SAN DIEGO, California, September 16 /PRNewswire/ -- Santaris Pharma A/S, a privately-held biopharmaceutical
company focused on developing RNA-based drugs targeted to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3652</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3652</guid>
				<pubDate>Wed, 16 Sep 2009 12:15:00 +0000</pubDate>
			</item>
					<item>
				<title>Linda Dyson Joins Cohn &amp; Wolfe as Global Healthcare Practice Leader</title>
				<description>NEW YORK, September 10 /PRNewswire/ -- Cohn &amp; Wolfe, a leading global public relations agency, today announced 
that Linda Dyson has joined the firm as Executive Vice President and Global 
Healthcare...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3613</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3613</guid>
				<pubDate>Thu, 10 Sep 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product &amp; Portfolio Strategy</title>
				<description>OXFORD, England, September 10 /PRNewswire/ -- PharmaVentures announced today the appointment of Nikki Watkins as Head
of the Product &amp; Portfolio Strategy Practice of Corporate Advisory, leading...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3611</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3611</guid>
				<pubDate>Thu, 10 Sep 2009 10:05:00 +0000</pubDate>
			</item>
					<item>
				<title>/C O R R E C T I O N -- Clinical Therapeutics/</title>
				<description>BRIDGEWATER, New Jersey, September 9 /PRNewswire/ -- In the news release, &quot;Clinical Therapeutics Announces the Addition of 
Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3610</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3610</guid>
				<pubDate>Thu, 10 Sep 2009 09:03:00 +0000</pubDate>
			</item>
					<item>
				<title>Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, &amp; Maternal Therapeutics Section</title>
				<description>BRIDGEWATER, England, September 9 /PRNewswire/ -- Clinical Therapeutics,( http://www.clinicaltherapeutics.com/) the world&#039;s
premier, rapid-publication journal, is proud to announce the addition...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3599</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3599</guid>
				<pubDate>Wed, 09 Sep 2009 09:30:00 +0000</pubDate>
			</item>
					<item>
				<title>New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group&#039;s American subsidiary, Helsinn Therapeutics (U.S.) Inc.</title>
				<description>LUGANO, Switzerland, September 9 /PRNewswire/ -- As part of the Helsinn Group&#039;s development strategy, William Mann, PhD,
has been appointed as new CEO in the American subsidiary, Helsinn
Therapeutics...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3598</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3598</guid>
				<pubDate>Wed, 09 Sep 2009 09:17:00 +0000</pubDate>
			</item>
					<item>
				<title>Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research &amp; Development</title>
				<description>COPENHAGEN and OSLO, September 1 /PRNewswire/ -- Affitech A/S, (Nasdaq OMX: AFFI), the antibody medicines
company, today announced that it has appointed two experienced biotech
executives to head its...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3557</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3557</guid>
				<pubDate>Tue, 01 Sep 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Aircraft Reports Material Expansion and Staff Increase</title>
				<description>EDINBURGH, Scotland, September 1 /PRNewswire/ -- Aircraft Medical (Aircraft), the UK medical devices company,
announces that it has added 25 new staff to its R&amp;D, business development and
sales teams...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3547</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3547</guid>
				<pubDate>Tue, 01 Sep 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed</title>
				<description>BOZEN, Italy, August 31 /PRNewswire/ -- Health Robotics today announced that National Taiwan University Hospital
(NTUH) has purchased and agreed to immediately install its flagship CytoCare
Robot...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3542</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3542</guid>
				<pubDate>Mon, 31 Aug 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Charlie Buckwell Appointed Medical Communications Head, Further Advancing McCann Healthcare Worldwide&#039;s Global Capabilities</title>
				<description>NEW YORK, August 21 /PRNewswire/ -- McCann Healthcare Worldwide is re-aligning and expanding its medical
communications businesses, to build a dedicated, unified and empowered
medical communications...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3494</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3494</guid>
				<pubDate>Fri, 21 Aug 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>AdvanDx Closes US$8 Million Financing Round and Elects New Board Member</title>
				<description>WOBURN, Massachusetts and VEDBAEK, Denmark, August 18 /PRNewswire/ -- AdvanDx today announced it has closed another US$8 million in financing
from existing stockholders, SLS Venture and LD Pensions....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3479</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3479</guid>
				<pubDate>Tue, 18 Aug 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors</title>
				<description>PALO ALTO, California, August 17 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a biotechnology company developing
antiviral therapies with a focus on the NS4B Hepatitis C Virus (HCV)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3476</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3476</guid>
				<pubDate>Mon, 17 Aug 2009 15:48:00 +0000</pubDate>
			</item>
					<item>
				<title>Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors</title>
				<description>AURORA, Ontario, August 17 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: HBP / OTCQX: HXBPF) today announced the
appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its board of
directors....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3475</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3475</guid>
				<pubDate>Mon, 17 Aug 2009 14:15:00 +0000</pubDate>
			</item>
					<item>
				<title>Bill &amp; Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office</title>
				<description>SEATTLE, August 13 /PRNewswire/ -- The Bill &amp; Melinda Gates Foundation today announced that Joe Cerrell has
been appointed to head its new European office in London, effective January
1, 2010....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3468</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3468</guid>
				<pubDate>Thu, 13 Aug 2009 10:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Terumo Heart Names Tom Gould and Mark Bullivant to Senior Management Positions in Left Ventricular Assist Device Market</title>
				<description>ANN ARBOR, Michigan, August 5 /PRNewswire/ -- Terumo Heart, Inc., a wholly owned subsidiary of Terumo Corporation,
today announced that it has named Thomas (Tom) B. Gould as Vice President,
Clinical...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3442</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3442</guid>
				<pubDate>Wed, 05 Aug 2009 12:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board</title>
				<description>CAMBRIDGE, Massachusetts, July 27 /PRNewswire/ -- Solace Pharmaceuticals, a private biotechnology company discovering and
developing innovative treatments for pain, announced that David Julius,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3407</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3407</guid>
				<pubDate>Mon, 27 Jul 2009 10:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Pulmonx Announces New President and CEO Michael A. Baker to Lead Interventional Pulmonology Company</title>
				<description>REDWOOD CITY, California, July 16 /PRNewswire/ -- Pulmonx, an emerging leader in interventional pulmonology and in the
development of device therapies for the treatment of emphysema announced
today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3377</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3377</guid>
				<pubDate>Thu, 16 Jul 2009 01:29:00 +0000</pubDate>
			</item>
					<item>
				<title>Sirius Genomics Announces 2009 Board of Directors</title>
				<description>VANCOUVER, June 8 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced 
that it has elected its 2009 Board of Directors at its recent Annual General 
Meeting. The...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3175</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3175</guid>
				<pubDate>Mon, 08 Jun 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support</title>
				<description>PHILADELPHIA, May 27 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and
medical information, announced today that Chris Dillon has joined Elsevier
Health Sciences as...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3113</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3113</guid>
				<pubDate>Wed, 27 May 2009 09:05:00 +0000</pubDate>
			</item>
					<item>
				<title>Leading Eye Doctor Takes Helm of Africa Portfolio in Operation Eyesight&#039;s Fight to End Avoidable Blindness</title>
				<description>TORONTO, May 27 /PRNewswire/ -- One of Africa&#039;s leading ophthalmologists has been appointed Regional 
Director for Africa for Operation Eyesight Universal, effective immediately.

    Dr. Boateng...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3111</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3111</guid>
				<pubDate>Wed, 27 May 2009 06:38:00 +0000</pubDate>
			</item>
					<item>
				<title>Elsevier Health Sciences Appoints Dr. David Goldmann Editor-in-Chief of its First Consult Point of Care Resource</title>
				<description>PHILADELPHIA, Pennsylvania, May 4 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and
medical information, announced today that Dr. David Goldmann has joined
Elsevier Health...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2992</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2992</guid>
				<pubDate>Mon, 04 May 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Nfocus Neuromedical Appoints Robert O&#039;Holla to Head Regulatory</title>
				<description>PALO ALTO, California, April 30 /PRNewswire/ -- Endovascular device start-up Nfocus Neuromedical Inc. announced today the
appointment of accomplished regulatory executive Robert O&#039;Holla to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2983</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2983</guid>
				<pubDate>Thu, 30 Apr 2009 21:50:00 +0000</pubDate>
			</item>
					<item>
				<title>Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board</title>
				<description>PALO ALTO, California, April 30 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today that its directors elected Eric
P. Milledge as Chairman of the Board. &quot;Mr. Milledge brings...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2982</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2982</guid>
				<pubDate>Thu, 30 Apr 2009 21:38:00 +0000</pubDate>
			</item>
					<item>
				<title>PhotoThera Closes US$50 Million Financing, Announces New President and Chief Executive Officer</title>
				<description>CARLSBAD, California, April 30 /PRNewswire/ -- PhotoThera, Inc., the developer of transcranial laser therapy (TLT)
designed for the treatment of acute ischemic stroke within 24 hours of stroke
onset,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2980</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2980</guid>
				<pubDate>Thu, 30 Apr 2009 17:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison</title>
				<description>COMMACK, New York, April 29 /PRNewswire/ -- It is with great privilege that Avery Biomedical Devices, Inc. (ABD)
announces the appointment of Abbott Krieger, M.D., F.A.C.S. as Chief...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2972</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2972</guid>
				<pubDate>Wed, 29 Apr 2009 19:32:00 +0000</pubDate>
			</item>
					<item>
				<title>2008 a Record Year for Gerresheimer</title>
				<description>DUSSELDORF, Germany, April 29 /PRNewswire/ -- The Annual General Meeting of Gerresheimer AG today passed an unchanged
dividend of EUR0.40 per share following the record year in 2008.

    The Company...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2970</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2970</guid>
				<pubDate>Wed, 29 Apr 2009 14:03:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire plc: Results of the Annual General Meeting Held on April 28, 2009</title>
				<description>DUBLIN, April 28 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that at its Annual General Meeting
today, all resolutions contained in...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2961</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2961</guid>
				<pubDate>Tue, 28 Apr 2009 16:36:00 +0000</pubDate>
			</item>
					<item>
				<title>Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency</title>
				<description>NEW YORK, April 28 /PRNewswire/ -- Diversified Agency Services (DAS) today announced the launch of
TogoRun(TM), a global healthcare communications agency with offices in New
York and London. TogoRun...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2960</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2960</guid>
				<pubDate>Tue, 28 Apr 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development</title>
				<description>STOCKHOLM, April 23 /PRNewswire/ -- Pharmalink AB today announced that it has strengthened its
Board of Directors as the company&#039;s portfolio continues to move towards late
stage product development...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2936</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2936</guid>
				<pubDate>Thu, 23 Apr 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs</title>
				<description>SOUTHAMPTON, England, April 21 /PRNewswire/ -- Vantia Therapeutics, a company developing novel small molecule
drugs targeting large underserved medical markets, today announces the
appointment of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2919</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2919</guid>
				<pubDate>Tue, 21 Apr 2009 11:05:00 +0000</pubDate>
			</item>
					<item>
				<title>Saebo United Kingdom Posts Record 2008; Sees Continued Growth in UK for 2009</title>
				<description>CHARLOTTE, North Carolina, April 16 /PRNewswire/ -- Saebo, Inc. announced in its first quarter that its subsidiary, Saebo UK,
Ltd., had another record year in 2008 and has added staff to accommodate...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2898</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2898</guid>
				<pubDate>Thu, 16 Apr 2009 17:14:00 +0000</pubDate>
			</item>
					<item>
				<title>Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer</title>
				<description>NOVATO, California, April 13 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (&quot;Raptor&quot; or the &quot;Company&quot;) (OTC Bulletin
Board: RPTP) today announced the appointment of Patrice P. Rioux, M.D.,
Ph.D., as...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2876</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2876</guid>
				<pubDate>Mon, 13 Apr 2009 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.</title>
				<description>NEW YORK, April 13 /PRNewswire/ -- A top biotech executive, William Pursley, has agreed to become Chairman
of Rx for Africa, Inc.&#039;s (Pink Sheets: RXAF) newly created Business Advisory
Board. For 25...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2874</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2874</guid>
				<pubDate>Mon, 13 Apr 2009 08:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business</title>
				<description>BALTIMORE, April 8 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company
engaged in the development of advanced preclinical platforms and tumor
specific data to enhance...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2857</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2857</guid>
				<pubDate>Wed, 08 Apr 2009 08:22:00 +0000</pubDate>
			</item>
					<item>
				<title>Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush</title>
				<description>PARIS, March 26 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the
discovery and development of novel antibiotics designed to overcome the
significant global problem of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2784</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2784</guid>
				<pubDate>Thu, 26 Mar 2009 08:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Dr. Thomas Werner Elected to Accera, Inc.&#039;s Board of Directors</title>
				<description>BROOMFIELD, Colorado, March 24 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies
in central nervous system (CNS) diseases, announced today that Thomas...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2766</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2766</guid>
				<pubDate>Tue, 24 Mar 2009 14:17:00 +0000</pubDate>
			</item>
					<item>
				<title>Victory Pharma Announces US$45 Million Equity Financing</title>
				<description>SAN DIEGO, March 9 /PRNewswire/ -- Victory Pharma, Inc. (&quot;Victory&quot; or &quot;the Company&quot;), a privately held
specialty pharmaceutical company, today announced that it has closed on a
US$45 million equity...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2679</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2679</guid>
				<pubDate>Mon, 09 Mar 2009 07:17:00 +0000</pubDate>
			</item>
					<item>
				<title>Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board</title>
				<description>HUNTINGTON BEACH, California and AMSTERDAM, March 5 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today
announced the appointment of Dr. Albert A. (Al) Luderer to its...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2671</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2671</guid>
				<pubDate>Thu, 05 Mar 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Chiltern Appoints Jane Turner as Late Phase Director for Europe</title>
				<description>LONDON, February 27 /PRNewswire/ -- Chiltern a leading global clinical research organization announced today
that it has appointed Ms. Jane Turner to the post of Director, Late Phase,
Europe.

   ...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2635</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2635</guid>
				<pubDate>Fri, 27 Feb 2009 20:08:00 +0000</pubDate>
			</item>
					<item>
				<title>The Walter and Eliza Hall Institute Announces the Next Director</title>
				<description>MELBOURNE, Australia, February 24 /PRNewswire/ -- The Board of the Walter and Eliza Hall Institute (WEHI) has announced
that Professor Doug Hilton will be the Institute&#039;s next Director.

   ...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2601</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2601</guid>
				<pubDate>Tue, 24 Feb 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire Announces Opening of Office in Japan</title>
				<description>TOKYO, Japan and CAMBRIDGE, Massachusetts, February 20 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced today that it has officially...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2590</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2590</guid>
				<pubDate>Fri, 20 Feb 2009 15:23:00 +0000</pubDate>
			</item>
					<item>
				<title>Agendia Appoints VP of Business Development</title>
				<description>HUNTINGTON BEACH, California and AMSTERDAM, The Netherlands, February 11 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced
the appointment of Alan B. Carter as...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2541</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2541</guid>
				<pubDate>Wed, 11 Feb 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Jean-Pierre Lehner Appointed Chief Medical Officer</title>
				<description>PARIS, February 11 /PRNewswire/ -- Sanofi-aventis announced today that Jean-Pierre Lehner, M.D., is
appointed Senior Vice-President, Chief Medical Officer (CMO). He was
previously Senior Vice...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2539</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2539</guid>
				<pubDate>Wed, 11 Feb 2009 08:44:00 +0000</pubDate>
			</item>
					<item>
				<title>Elias Zerhouni, Scientific Advisor to the Chief Executive Officer</title>
				<description>PARIS, February 11 /PRNewswire/ -- Sanofi-aventis is pleased to announce the collaboration with Dr. Elias
Zerhouni as Scientific Advisor to the Chief Executive Officer, Christopher A.
Viehbacher and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2538</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2538</guid>
				<pubDate>Wed, 11 Feb 2009 08:32:00 +0000</pubDate>
			</item>
					<item>
				<title>January 2009 - Rahu Appoints David Greensmith to Non Executive Directo</title>
				<description>NOTTINGHAM, England, February 2 /PRNewswire/ -- David has enjoyed a long and highly successful career in the global
chemical sector including Managing Director Fujifilm, Chief Operating Officer
of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2505</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2505</guid>
				<pubDate>Mon, 02 Feb 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>NeuroFocus Names John Polich, World-Renowned Scientist in Brain Function and Cognition, to Head Global NeuroLab Operations</title>
				<description>BERKELEY, California, January 28 /PRNewswire/ -- NeuroFocus, the world leader in the rapidly-growing field of
neuromarketing, announced today that it has named preeminent cognitive
neuroscientist...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2487</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2487</guid>
				<pubDate>Wed, 28 Jan 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT CEO Ronald Lorijn Steps Down</title>
				<description>AMSTERDAM, January 22 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, announced today that Dr. Ronald H.W. Lorijn
will for personal...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2458</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2458</guid>
				<pubDate>Thu, 22 Jan 2009 19:48:00 +0000</pubDate>
			</item>
					<item>
				<title>Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office</title>
				<description>DENVER, January 21 /PRNewswire/ -- eTrinsic, a division of Simbionix USA Corporation (Simbionix), a
developer of online medical education products and technology for training
medical salespeople and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2444</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2444</guid>
				<pubDate>Wed, 21 Jan 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect</title>
				<description>WASHINGTON, January 13 /PRNewswire/ -- The Association of Clinical Research Organizations (ACRO), which
represents the clinical outsourcing industry to regulators, biopharmaceutical
clients, policy...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2402</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2402</guid>
				<pubDate>Tue, 13 Jan 2009 14:35:00 +0000</pubDate>
			</item>
					<item>
				<title>French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees)</title>
				<description>PARIS, January 12 /PRNewswire/ -- The French agency Agence de M</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2385</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2385</guid>
				<pubDate>Mon, 12 Jan 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Agendia Appoints New Chief Financial Officer</title>
				<description>HUNTINGTON BEACH, California, and AMSTERDAM, January 8 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced
the appointment of Kurt Schmidt, CPA, MBA, as the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2375</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2375</guid>
				<pubDate>Thu, 08 Jan 2009 16:27:00 +0000</pubDate>
			</item>
					<item>
				<title>Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager</title>
				<description>SAN DIEGO, January 8 /PRNewswire/ -- Amira Pharmaceuticals, a small molecule pharmaceutical company focused on
the discovery and early development of compounds to treat inflammatory
diseases, today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2374</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2374</guid>
				<pubDate>Thu, 08 Jan 2009 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer</title>
				<description>AMSTERDAM, January 6 /PRNewswire/ -- Biopharmaceutical Company Kiadis Pharma focused on the development of
innovative cell based therapeutics in the field of bone marrow
transplantation, announces...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2358</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2358</guid>
				<pubDate>Tue, 06 Jan 2009 09:53:00 +0000</pubDate>
			</item>
					<item>
				<title>Xceleron Names Michael Butler as President &amp;amp; CEO</title>
				<description>GAITHERSBURG, Maryland and YORK, England, December 16 /PRNewswire/ -- Xceleron, the global leader in predictive clinical research to enable
smarter, safer drug development, announced today Michael...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2316</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2316</guid>
				<pubDate>Tue, 16 Dec 2008 16:34:00 +0000</pubDate>
			</item>
					<item>
				<title>Algeta Appoints Andrew Kay as President and Chief Executive Officer</title>
				<description>OSLO, December 11 /PRNewswire/ -- Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company,
announces that Mr. Andrew Kay has been appointed as President and Chief
Executive Officer and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2287</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2287</guid>
				<pubDate>Thu, 11 Dec 2008 13:21:00 +0000</pubDate>
			</item>
					<item>
				<title>Enigma Diagnostics Announces the Opening of a United States Office</title>
				<description>PORTON DOWN, England and SAN FRANCISCO, December 2 /PRNewswire/ -- Enigma Diagnostics, the decentralized and point-of-care molecular
diagnostics company, announced today the opening of a new U.S....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2235</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2235</guid>
				<pubDate>Tue, 02 Dec 2008 13:46:00 +0000</pubDate>
			</item>
					<item>
				<title>Sentillion Appoints New UK Sales Manager</title>
				<description>LONDON, November 26 /PRNewswire/ -- Sentillion, the identity and access management (IAM) specialist for the
healthcare sector, has today announced the appointment of Colin Wicks as UK
Regional Sales...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2200</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2200</guid>
				<pubDate>Wed, 26 Nov 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Sir Richard Sykes Appointed as Advisory Board Member of Siemens Holdings plc</title>
				<description>FRIMLEY, England, November 24 /PRNewswire/ -- Siemens has today announced the appointment of internationally
renowned microbiologist and former chairman of GlaxoSmithKline, Sir Richard
Sykes, as an...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2190</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2190</guid>
				<pubDate>Mon, 24 Nov 2008 11:47:00 +0000</pubDate>
			</item>
					<item>
				<title>Dr Martin Read Appointed as Advisory Board Member of Siemens Holdings plc</title>
				<description>FRIMLEY, England, November 24 /PRNewswire/ -- Siemens today announced the appointment of Dr Martin Read as an advisory
board member of Siemens Holdings plc.

    Andreas J Goss, chief executive,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2189</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2189</guid>
				<pubDate>Mon, 24 Nov 2008 11:20:00 +0000</pubDate>
			</item>
					<item>
				<title>Avantium Further Strengthens its Pharma Business Development Team</title>
				<description>AMSTERDAM, The Netherlands, November 18 /PRNewswire/ -- Avantium Technologies announced today that Bernard Mulder, MD, MBA, has
joined Avantium to lead the business development team for its...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2149</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2149</guid>
				<pubDate>Tue, 18 Nov 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Karolinska Development Strengthens its Management Team With the Appointment of Dr Carl Harald Janson</title>
				<description>STOCKHOLM, November 13 /PRNewswire/ -- Karolinska Development AB, a Swedish investment company using a unique,
highly cost effective model to commercialize internationally renowned life
science...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2123</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2123</guid>
				<pubDate>Thu, 13 Nov 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board</title>
				<description>LOUISVILLE, Kentucky, November 11 /PRNewswire/ -- Potentia Pharmaceuticals, a privately held biotechnology company
developing medicines for the treatment of age-related macular degeneration
(AMD),...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2102</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2102</guid>
				<pubDate>Tue, 11 Nov 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Jonathan Jacobson Appointed General Manager, Global Business Strategies &amp;amp; Operations, Menicon Co., Ltd.</title>
				<description>NAGOYA, Japan, November 10 /PRNewswire/ -- Menicon Co., Ltd. announced the appointment of Jonathan Jacobson as
General Manager, Global Business Strategies &amp;amp; Operations, effective November
10....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2087</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2087</guid>
				<pubDate>Mon, 10 Nov 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Trillium Strengthens its Board of Directors</title>
				<description>TORONTO, November 5 /PRNewswire/ -- Trillium Therapeutics Inc., a privately held biopharmaceutical company,
announced today that industry veterans Dr. Michael Berendt and Dr. John
Dietrich have...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2053</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2053</guid>
				<pubDate>Wed, 05 Nov 2008 12:30:00 +0000</pubDate>
			</item>
					<item>
				<title>William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionix&#039;s Strategic Expansion in the US Market</title>
				<description>CLEVELAND, Ohio and LOD, Israel, November 3 /PRNewswire/ -- Simbionix USA Corporation (Simbionix), a developer of medical
simulators and hands-on curriculum for training medical professionals,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2041</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2041</guid>
				<pubDate>Mon, 03 Nov 2008 08:51:00 +0000</pubDate>
			</item>
					<item>
				<title>New Chief Executive Officer Joins International Diabetes Federation</title>
				<description>BRUSSELS, November 3 /PRNewswire/ -- The International Diabetes Federation (IDF) announced today that Ms Ann
Keeling has joined the organization as Chief Executive Officer/Executive
Director.

   ...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2034</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2034</guid>
				<pubDate>Mon, 03 Nov 2008 00:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Continua Health Alliance Advances Mission to Create Connected Personal Health Ecosystem</title>
				<description>PORTLAND, Oregon, October 21 /PRNewswire/ -- The Continua Health Alliance, an organization dedicated to enabling
interoperable healthcare products and solutions worldwide, today announced
the first...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1952</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1952</guid>
				<pubDate>Tue, 21 Oct 2008 14:43:00 +0000</pubDate>
			</item>
					<item>
				<title>Mentice Appoints Bj</title>
				<description>GOTHENBURG, Sweden, October 13 /PRNewswire/ -- Mentice, a leading supplier of solutions for medical simulation,
announces the appointment of Mr. Bj</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1903</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1903</guid>
				<pubDate>Mon, 13 Oct 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Evalve Expands Executive Leadership Team</title>
				<description>MENLO PARK, California, October 9 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the
percutaneous repair of cardiac valves, has expanded its sales and marketing
executive...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1891</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1891</guid>
				<pubDate>Thu, 09 Oct 2008 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio</title>
				<description>COPENHAGEN, October 8 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today that it is discontinuing
development of zanolimumab (HuMax-CD4(R)). In addition, as a result of a
portfolio review and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1884</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1884</guid>
				<pubDate>Wed, 08 Oct 2008 15:31:00 +0000</pubDate>
			</item>
					<item>
				<title>Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board</title>
				<description>RICHMOND, California, October 1 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in the development of new
proprietary fluorescent metal-lanthanide technology for use in...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1829</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1829</guid>
				<pubDate>Wed, 01 Oct 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Appointment Notice - Comprehensive Care International Appoints Healthcare Executive Anthony DiCaita as Project Director for Children&#039;s Cancer Hospital 57357</title>
				<description>TORONTO, September 29 /PRNewswire/ -- Comprehensive Care International (CCI), is pleased to announce the
appointment of Anthony DiCaita, CMA, CHE, MBA, MPA, as Project Director for
the Children&#039;s...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1821</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1821</guid>
				<pubDate>Mon, 29 Sep 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire Limited: Results of the Annual General Meeting Held on September 24, 2008</title>
				<description>DUBLIN, Ireland, September 24 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that at its Annual General Meeting
today, all...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1797</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1797</guid>
				<pubDate>Wed, 24 Sep 2008 14:48:00 +0000</pubDate>
			</item>
					<item>
				<title>SoluBest Appoints Michael Sheckler, MBA, as CEO</title>
				<description>TEL AVIV, Israel, September 10 /PRNewswire/ -- SoluBest Ltd., a privately held, clinical stage developer of a novel
solubilizing technology, has appointed Michael Sheckler, MBA, as CEO. Mr.
Sheckler...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1698</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1698</guid>
				<pubDate>Wed, 10 Sep 2008 13:54:00 +0000</pubDate>
			</item>
					<item>
				<title>InNexus Biotechnology Strengthens Patent Team With New Leadership</title>
				<description>BRITISH COLUMBIA, Canada, September 9 /PRNewswire/ -- InNexus Biotechnology Inc., (TSX: IXS.V, OTC Bulletin Board: IXSBF,
http://www.ixsbio.com), a drug development company commercializing the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1687</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1687</guid>
				<pubDate>Tue, 09 Sep 2008 14:25:00 +0000</pubDate>
			</item>
					<item>
				<title>ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer</title>
				<description>LEUVEN, Belgium, August 28 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology
company focused on novel therapies for eye disease, vascular disease and
cancer, announces today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1591</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1591</guid>
				<pubDate>Thu, 28 Aug 2008 17:04:00 +0000</pubDate>
			</item>
					<item>
				<title>Essilor : Nomination of Hubert Sagnieres</title>
				<description>CHARENTON-LE-PONT, France, August 28 /PRNewswire/ -- The Board of Directors of Essilor International today
appointed Hubert Sagnieres as Chief Operating Officer, to serve alongside
Xavier Fontanet,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1585</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1585</guid>
				<pubDate>Thu, 28 Aug 2008 06:41:00 +0000</pubDate>
			</item>
					<item>
				<title>Australian to Lead the World in Cancer Fight</title>
				<description>MELBOURNE, Australia, August 27 /PRNewswire/ -- Professor David Hill, Director of The Cancer Council Victoria, will
commence in his role as President of the International Union Against Cancer
(UICC)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1575</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1575</guid>
				<pubDate>Wed, 27 Aug 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Allied World Assurance Company Appoints Patrick de Saint-Aignan to Board of Directors</title>
				<description>PEMBROKE, Bermuda, August 26 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today announced
the appointment of Patrick de Saint-Aignan to its Board of Directors. Mr....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1570</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1570</guid>
				<pubDate>Tue, 26 Aug 2008 20:00:00 +0000</pubDate>
			</item>
					<item>
				<title>UltraShape Appoints Assaf Eyal as President &amp;amp; CEO</title>
				<description>YOQNEAM, Israel and SAN RAMON, California, August 26 /PRNewswire/ -- UltraShape, the global leader in non-invasive fat reduction and body 
contouring, announced today the appointment of Assaf Eyal as...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1565</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1565</guid>
				<pubDate>Tue, 26 Aug 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Chiltern&#039;s Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom</title>
				<description>LONDON, August 7 /PRNewswire/ -- Chiltern, a leading global research organization, announced that it has
appointed new staff in strategic locations to support the large growth in
their Resourcing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1497</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1497</guid>
				<pubDate>Thu, 07 Aug 2008 05:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer</title>
				<description>TEL AVIV, Israel, BADAJOZ, Spain and SINGAPORE, August 5 /PRNewswire/ -- Pollogen Ltd. announced that Ms. Yfat Scialom has been
appointed as the new Chief Executive Officer effective July 20, 2008.

...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1488</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1488</guid>
				<pubDate>Tue, 05 Aug 2008 17:02:00 +0000</pubDate>
			</item>
					<item>
				<title>Assist America Appoints Abhijit Bhandari as Director of Sales &amp;amp; Marketing for the Middle East</title>
				<description>PRINCETON, New Jersey, July 25 /PRNewswire/ -- Assist America, Inc., the world&#039;s leading global emergency assistance
services provider through group benefit plans, announced today that...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1447</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1447</guid>
				<pubDate>Fri, 25 Jul 2008 16:38:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire Ltd.: Robin Buchanan to Step Down as Non-Executive Director on Completion of Term of Office</title>
				<description>BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, July 21 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company announces that non-executive...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1422</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1422</guid>
				<pubDate>Mon, 21 Jul 2008 12:12:00 +0000</pubDate>
			</item>
					<item>
				<title>Organizational Changes at Silence Therapeutics</title>
				<description>LONDON, July 17 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN), a leading European RNAi
focused biotechnology company, announces that for personal reasons,
Jeffery Vick has resigned as...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1411</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1411</guid>
				<pubDate>Thu, 17 Jul 2008 17:12:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT Appoints Director Global Marketing and Sales</title>
				<description>AMSTERDAM, The Netherlands, July 17 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, announced today the appointment of Mrs.
Janneke de...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1406</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1406</guid>
				<pubDate>Thu, 17 Jul 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board</title>
				<description>NOVATO, California, July 14 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced
the appointments of Richard L. Franklin, M.D., Ph.D. to the Company&#039;s board
of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1385</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1385</guid>
				<pubDate>Mon, 14 Jul 2008 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Cohn &amp;amp; Wolfe Launches GCI Health, One of the World&#039;s Largest Healthcare Public Relations Firms</title>
				<description>NEW YORK, July 9 /PRNewswire/ -- Cohn &amp;amp; Wolfe has announced the formation of GCI Health, a new global
healthcare public relations firm, specializing in all aspects of the
healthcare industry. GCI...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1370</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1370</guid>
				<pubDate>Wed, 09 Jul 2008 15:59:00 +0000</pubDate>
			</item>
					<item>
				<title>Physicians Practice Promotes Key Executives</title>
				<description>BALTIMORE, July 7 /PRNewswire/ -- Physicians Practice, America&#039;s Leading Practice Management Journal today
announced the promotions of Pamela L. Moore, Ph.D to editorial director,
Steven Gottshall to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1355</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1355</guid>
				<pubDate>Mon, 07 Jul 2008 17:18:00 +0000</pubDate>
			</item>
					<item>
				<title>A New President at the Head of the Genethon Laboratory</title>
				<description>EVRY, France, July 7 /PRNewswire/ -- The board of directors at Genethon nominated a new president
to head the laboratory created in 1990 by the AFM (French Muscular Dystrophy
Association). Thus Yves...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1352</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1352</guid>
				<pubDate>Mon, 07 Jul 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Nabriva Therapeutics Announces Appointment of New CEO</title>
				<description>VIENNA, Austria, July 3 /PRNewswire/ -- Nabriva Therapeutics, a specialist in antibiotics development, announces
that Dr. George Golumbeski has been appointed as Chief Executive Officer of
the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1337</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1337</guid>
				<pubDate>Thu, 03 Jul 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Silence Therapeutics Announces Board Changes</title>
				<description>LONDON, July 1 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN) (&#039;the Company&#039;) today
announced changes to its Board of Directors as part of the company&#039;s plan for
growth.

    Effective...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1329</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1329</guid>
				<pubDate>Tue, 01 Jul 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors</title>
				<description>BANNOCKBURN, Illinois, July 1 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech
solutions company today announced it has entered into a lease agreement...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1326</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1326</guid>
				<pubDate>Tue, 01 Jul 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Nucletron Appoints New Chief Executive Officer</title>
				<description>VEENENDAAL, The Netherlands, June 30 /PRNewswire/ -- Nucletron announced today the appointment of Jos Lamers as its new chief
executive officer. The appointment marks the next phase for the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1319</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1319</guid>
				<pubDate>Mon, 30 Jun 2008 09:16:00 +0000</pubDate>
			</item>
					<item>
				<title>Niutang Recruits Seasoned Executive to Open U.K. Office</title>
				<description>CHANGZHOU, China, June 23 /PRNewswire/ -- Niutang Chemical, a leading global manufacturer of food additives,
pharmaceutical intermediates and curing agents, has recruited Alan Turner to
lead its new...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1268</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1268</guid>
				<pubDate>Mon, 23 Jun 2008 17:07:00 +0000</pubDate>
			</item>
					<item>
				<title>Bruce Palsulich Joins Relsys International as Chief Innovation &amp;amp; Strategy Officer</title>
				<description>IRVINE, California, June 23 /PRNewswire/ -- Relsys International, the leading provider of drug safety,
pharmacovigilance and risk management solutions for the pharmaceutical
industry, announces that...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1258</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1258</guid>
				<pubDate>Mon, 23 Jun 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Senetek PLC Announces Key Personnel Appointments</title>
				<description>NAPA, California, June 9 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy aging,
today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1171</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1171</guid>
				<pubDate>Mon, 09 Jun 2008 15:09:00 +0000</pubDate>
			</item>
					<item>
				<title>Amira Pharmaceuticals Hires Industry Veteran for CFO Position</title>
				<description>SAN DIEGO, June 9 /PRNewswire/ -- Amira Pharmaceuticals, a small molecule pharmaceutical company focused on
the discovery and development of compounds to treat inflammatory diseases,
announced the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1170</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1170</guid>
				<pubDate>Mon, 09 Jun 2008 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Ex-Menarini Executive to Lead UK for WaveSense</title>
				<description>OXFORD, England, June 5 /PRNewswire/ -- WaveSense Europe announced today that Mr. Alec Winton, formerly of
Menarini Diagnostics, has joined WaveSense Europe as General Manager, UK, and
that WaveSense...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1151</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1151</guid>
				<pubDate>Thu, 05 Jun 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Genmab A/S - Changes Board/Management/Auditors</title>
				<description>COPENHAGEN, Denmark, June 2 /PRNewswire/ -- Genmab A/S (OMX: GEN) today announced that David A. Eatwell has been 
appointed Chief Financial Officer of the company. Mr. Eatwell will be 
responsible...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1131</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1131</guid>
				<pubDate>Mon, 02 Jun 2008 18:38:00 +0000</pubDate>
			</item>
					<item>
				<title>Nventa Appoints Gordon H. Busenbark to Board of Directors</title>
				<description>SAN DIEGO, May 28 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today the
appointment of Gordon H. Busenbark to the company&#039;s board of directors. Mr.
Busenbark currently...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1079</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1079</guid>
				<pubDate>Wed, 28 May 2008 12:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Allergy Standards Ltd. Appoints Angela Southey PhD as Scientific Officer</title>
				<description>DUBLIN, Ireland, May 22 /PRNewswire/ -- Allergy Standards Ltd. (&quot;ASL&quot;), the internationally recognized
independent evaluator of consumer products, today announced that Angela
Southey, PhD, has joined...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1056</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1056</guid>
				<pubDate>Thu, 22 May 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Teva Welcomes Recognition for Kim Innes as BGMA Chair</title>
				<description>LEEDS, England, May 20 /PRNewswire/ -- Teva UK Limited has welcomed the election of Kim Innes, Director of the
company&#039;s generics business, as Chairman of the British Generic...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1038</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1038</guid>
				<pubDate>Tue, 20 May 2008 09:18:00 +0000</pubDate>
			</item>
					<item>
				<title>New Supervisory Board Member for Gerresheimer</title>
				<description>DUSSELDORF, Germany, May 19 /PRNewswire/ -- Mr. Lionel Assant, Partner in Blackstone Group International Ltd., 
London, has resigned his Supervisory Board mandate with Gerresheimer AG.

    In his...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1030</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1030</guid>
				<pubDate>Mon, 19 May 2008 13:35:00 +0000</pubDate>
			</item>
					<item>
				<title>Chiltern Expands Its Global Reach to Latin America</title>
				<description>LONDON, May 19 /PRNewswire/ -- Chiltern, a leading global research organization, announced the
appointment of Mr. Oscar Podesta to the role of General Manager, Latin
America.

    The Latin American...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1020</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1020</guid>
				<pubDate>Mon, 19 May 2008 05:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Albireo Appoints Dr Hans Graffner as Chief Medical Officer</title>
				<description>GOTHENBURG, Sweden, May 15 /PRNewswire/ -- Albireo, a pharmaceutical company focusing on the development
of therapeutics for gastrointestinal diseases, announced today the
appointment of Hans...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/998</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/998</guid>
				<pubDate>Thu, 15 May 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>RPS Enhances Clinical Expertise and Leadership with Two Additions to Senior Management Team</title>
				<description>FORT WASHINGTON, Pennsylvania, May 14 /PRNewswire/ -- RPS, Inc. today announced the addition of two new members to its Senior
Management Team. David A. Green, Ph.D. joins RPS as Vice President...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/990</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/990</guid>
				<pubDate>Wed, 14 May 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ChemAxon Announces New CEO and Head of R&amp;amp;D</title>
				<description>BUDAPEST, Hungary, May 12 /PRNewswire/ -- ChemAxon, a software solutions provider for cheminformatics, today
announced the appointment of Alex Drijver as CEO. The arrival signals the
companies...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/967</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/967</guid>
				<pubDate>Mon, 12 May 2008 11:19:00 +0000</pubDate>
			</item>
					<item>
				<title>Nventa Appoints John Varian to Board of Directors</title>
				<description>SAN DIEGO, May 7 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today the
appointment of John Varian to the company&#039;s board of directors. Mr. Varian
currently serves as...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/940</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/940</guid>
				<pubDate>Wed, 07 May 2008 12:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Basil Zimmo Joins Finesse Solutions as Vice-President of Software</title>
				<description>SANTA CLARA, California, May 7 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement
and control solutions for life sciences process applications, announced...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/932</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/932</guid>
				<pubDate>Wed, 07 May 2008 01:18:00 +0000</pubDate>
			</item>
					<item>
				<title>Kendle Appoints Patricia Williams Vice President, Commercial Operations</title>
				<description>CINCINNATI, May 6 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research
organization (CRO), today announced the appointment of Patricia Williams to
the position of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/931</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/931</guid>
				<pubDate>Tue, 06 May 2008 19:48:00 +0000</pubDate>
			</item>
					<item>
				<title>MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments</title>
				<description>GAITHERSBURG, Maryland, May 6 /PRNewswire/ -- MedImmune today announced that it has enhanced its leadership team to
guide the company&#039;s expanded product pipeline in the United States and abroad
as...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/927</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/927</guid>
				<pubDate>Tue, 06 May 2008 14:56:00 +0000</pubDate>
			</item>
					<item>
				<title>Jonas Ohlsson Appointed CEO/President of Cellectricon</title>
				<description>GOTHENBURG, Sweden, April 29 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug
discovery, announced today that its board of directors has appointed Jonas
Ohlsson as the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/936</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/936</guid>
				<pubDate>Tue, 29 Apr 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Jonas Ohlsson Appointed CEO/President of Cellectricon</title>
				<description>GOTHENBURG, Sweden, April 29 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug
discovery, announced today that its board of directors has appointed Jonas
Ohlsson as the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/890</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/890</guid>
				<pubDate>Tue, 29 Apr 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Dr Michael Rosenblatt Appointed Non-Executive Director at Shire</title>
				<description>BASINGSTOKE, England, April 24 /PRNewswire/ -- The Board of Directors of Shire plc (LSE: SHP) (NASDAQ: SHPGY), the
global specialty biopharmaceutical company, announces today that Michael
Rosenblatt...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/860</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/860</guid>
				<pubDate>Thu, 24 Apr 2008 16:55:00 +0000</pubDate>
			</item>
					<item>
				<title>4SC AG Announces Change in the Supervisory Board</title>
				<description>PLANEGG-MARTINSRIED, Germany, April 24 /PRNewswire/ -- The Martinsried-based drug discovery and development company 4SC AG
(Frankfurt, Prime Standard: VSC) announced today that the current...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/854</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/854</guid>
				<pubDate>Thu, 24 Apr 2008 08:28:00 +0000</pubDate>
			</item>
					<item>
				<title>Passing of Genmab A/S&#039; Annual General Meeting</title>
				<description>COPENHAGEN, April 23 /PRNewswire/ -- Summary: At Genmab A/S&#039; Annual General Meeting held today on April 23,
2008 the Annual Report for 2007 was approved, discharge was given to the
Board of Directors...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/845</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/845</guid>
				<pubDate>Wed, 23 Apr 2008 16:43:00 +0000</pubDate>
			</item>
					<item>
				<title>Quintiles Consulting Business Expands</title>
				<description>RESEARCH TRIANGLE PARK, North Carolina, April 22 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of three
new practice leaders and a business development head as part of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/837</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/837</guid>
				<pubDate>Tue, 22 Apr 2008 21:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Quintiles Appoints Oren Cohen to Senior Vice President, Clinical Research Strategies</title>
				<description>RESEARCH TRIANGLE PARK, North Carolina, April 16 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of Oren
Cohen, M.D. as Senior Vice President, Clinical Research...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/806</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/806</guid>
				<pubDate>Wed, 16 Apr 2008 14:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Maria Sainz Named President and CEO of Concentric Medical</title>
				<description>MOUNTAIN VIEW, California, April 11 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, today announced that Maria Sainz has been...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/771</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/771</guid>
				<pubDate>Fri, 11 Apr 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Stiefel Laboratories Appoints First Chief Scientific Officer</title>
				<description>CORAL GABLES, Florida, April 7 /PRNewswire/ -- Stiefel Laboratories, Inc., the world&#039;s largest independent
pharmaceutical company specializing in dermatology, today announced Gavin
Corcoran, M.D.,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/741</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/741</guid>
				<pubDate>Mon, 07 Apr 2008 16:19:00 +0000</pubDate>
			</item>
					<item>
				<title>Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board</title>
				<description>AMSTERDAM, The Netherlands, April 2 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field 
of human gene therapy, today announced that AMT&#039;s Supervisory Board has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/720</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/720</guid>
				<pubDate>Wed, 02 Apr 2008 11:32:00 +0000</pubDate>
			</item>
					<item>
				<title>Agendia Appoints Oncologist Richard A. Bender as Vice President and Chief Medical Officer</title>
				<description>AMSTERDAM, Netherlands, April 1 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of cancer
molecular diagnostics, today announced the appointment of Richard A. Bender,
MD,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/657</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/657</guid>
				<pubDate>Tue, 01 Apr 2008 14:26:00 +0000</pubDate>
			</item>
					<item>
				<title>Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors</title>
				<description>SAN DIEGO, March 31 /PRNewswire/ -- Amira Pharmaceuticals, a small molecule pharmaceutical company focused on
the discovery and development of compounds to treat inflammatory disease,
today announced...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/643</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/643</guid>
				<pubDate>Mon, 31 Mar 2008 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>DARA BioSciences, Inc. Announces New Officer and Director Appointments</title>
				<description>RALEIGH, North Carolina, March 25 /PRNewswire/ -- DARA BioSciences(TM) (Nasdaq: DARA) announced today the appointment of
John Didsbury, Ph.D. as President and Chief Operating Officer. Dr....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/611</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/611</guid>
				<pubDate>Tue, 25 Mar 2008 16:52:00 +0000</pubDate>
			</item>
					<item>
				<title>Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer</title>
				<description>YOKNEAM, Israel and PLYMOUTH MEETING, Pennsylvania, March 25 /PRNewswire/ -- Galil Medical, a global cryotherapy company, today announced that Martin
J. Emerson has been appointed President and Chief...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/609</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/609</guid>
				<pubDate>Tue, 25 Mar 2008 10:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Steve Glass Appointed Vice President and General Manager, BioMarin</title>
				<description>NOVATO, California and LONDON, January 22 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that
it has appointed Mr. Steve Glass as Vice President and General...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/605</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/605</guid>
				<pubDate>Sat, 22 Mar 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board</title>
				<description>AMSTERDAM, March 20 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced that AMT&#039;s Supervisory Board
has decided to propose...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/599</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/599</guid>
				<pubDate>Thu, 20 Mar 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Doncaster NHS Strike Set to Spread</title>
				<description>LONDON, March 14 /PRNewswire/ --     An ongoing strike involving maintenance craft workers at Doncaster and
Bassetlaw Hospitals NHS Foundation Trust is set to build and spread.

    24 Unite...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/709</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/709</guid>
				<pubDate>Fri, 14 Mar 2008 14:11:00 +0000</pubDate>
			</item>
					<item>
				<title>Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland</title>
				<description>BASEL, Switzerland, February 4 /PRNewswire/ -- Synosia Therapeutics today announced the appointment of
Philippe Lutz MA Finance, as the company&#039;s first chief financial officer,
effective immediately....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/572</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/572</guid>
				<pubDate>Mon, 04 Feb 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board</title>
				<description>AMSTERDAM, January 31 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced that further to its plan of
rotation to appoint...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/556</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/556</guid>
				<pubDate>Thu, 31 Jan 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board</title>
				<description>ORLANDO, Florida, January 30 /PRNewswire/ -- John Wagner, M.D., recognized as a leader in the field of cord blood stem 
cell transplantation, has joined the team at CORD:USE Cord Blood Bank. Dr....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/555</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/555</guid>
				<pubDate>Wed, 30 Jan 2008 20:38:00 +0000</pubDate>
			</item>
						<atom:link href="http://pharmalicensing.com/public/public/news/newsmlrss/294/Personnel_Announcements" rel="self" type="application/rss+xml" />
	</channel>
</rss>
